Protective effect of cyclophilin A against Alzheimer's amyloid beta-peptide (25-35)-induced oxidative stress in PC12 cells

Chinese Medical Journal

Volumn 122, Issue 6, 2009, Pages 716-724

  Ge, Yu Song ^a   Teng, Wei Yu ^a   Zhang, Chao Dong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

amyloid; Alzheimer's disease; Apoptosis; Cyclophilin A; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CASPASE 3; CYCLOPHILIN A; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; RECOMBINANT CYCLOPHILIN A; RECOMBINANT ENZYME; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (25-35); PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STRAIN; CELL STRESS; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; ENZYME ACTIVITY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; ANIMAL; DRUG EFFECT; HUMAN; METABOLISM;

AMYLOID BETA-PROTEIN; ANIMALS; CASPASE 3; CYCLOPHILIN A; GLUTATHIONE PEROXIDASE; HUMANS; OXIDATIVE STRESS; PC12 CELLS; PEPTIDE FRAGMENTS; RATS; SUPEROXIDE DISMUTASE;

EID: 67649804655     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.06.024     Document Type: Article

References (43)

1. Selkoe DJ. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 2001; 3: 75-80.
2. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356.
3. Abramov AY, Canevari L, Duchen MR. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci 2003; 15: 5088-5095.
4. Crack PJ, Cimdins K, Ali U, Hertzog PJ, Iannello RC. Lack of glutathione peroxidase-1 exacerbates Abeta-mediated neurotoxicity in cortical neurons. J Neural Transm 2006; 113: 645-657.
5. Fukui K, Takatsu H, Shinkai T, Suzuki S, Abe K, Urano S. Appearance of amyloid beta-like substances and delayed-type apoptosis in rat hippocampus CA1 region through aging and oxidative stress. J Alzheimers Dis 2005; 8: 299-309.
6. Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K, et al. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 2005; 12: 19-24.
7. Lee SY, Lee JW, Lee H, Yoo HS, Yun YP, Oh KW, et al. Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain Res Mol Brain Res 2005; 140: 45-54.
8. Wang P, Heitman J. The cyclophilins. Genome Biol 2005; 6: 226.
9. Arévalo-Rodríguez M, Heitman J. Cyclophilin A is localized to the nucleus and controls meiosis in Saccharomyces cerevisiae. Eukaryot Cell 2005; 4: 17-29.
10. Chiu R, Rey O, Zheng JQ, Twiss JL, Song J, Pang S, et al. Effects of altered expression and localization of cyclophilin A on differentiation of p19 embryonic carcinoma cells. Cell Mol Neurobiol 2003; 23: 929-943.
11. Sherry B, Yarlett N, Strupp A, Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci U S A 1992; 89: 3511-3515.
12. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991; 66: 807-815.
13. Ou WB, Luo W, Park YD, Zhou HM. Chaperone-like activity of peptidyl-prolyl cis-trans isomerase during creatine kinase refolding. Protein Sci 2001; 10: 2346-2353.
14. Galigniana MD, Morishima Y, Gallay PA, Pratt WB. Cyclophilin-A is bound through its peptidylprolyl isomerase domain to the cytoplasmic dynein motor protein complex. J Biol Chem 2004; 279: 55754-55759.
15. + T cells via a proline-directed conformational switch in Itk. Immunity 2004; 21: 189-201.
16. Helekar SA, Patrick J. Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homo-oligomeric receptor expression. Proc Natl Acad Sci U S A 1997; 94: 5432-5437.
17. Kim SH, Lessner SM, Sakurai Y, Galis ZS. Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am J Pathol 2004; 164: 1567-1574.
18. Ryffel B, Woerly G, Greiner B, Haendler B, Mihatsch MJ, Foxwell BM. Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology 1991; 72: 399-404.
19. Göldner FM, Patrick JW. Neuronal localization of the cyclophilin A protein in the adult rat brain. J Comp Neurol 1996; 372: 283-293.
20. Boulos S, Meloni BP, Arthur PG, Majda B, Bojarski C, Knuckey NW. Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury. Neurobiol Dis 2007; 25: 54-64.
21. Redell JB, Zhao J, Dash PK. Acutely increased cyclophilin a expression after brain injury: a role in blood-brain barrier function and tissue preservation. J Neurosci Res 2007; 85: 1980-1988.
22. Seko Y, Fujimura T, Taka H, Mineki R, Murayama K, Nagai R. Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem Biophys Res Commun 2004; 317: 162-168.
23. Hong F, Lee J, Song JW, Lee SJ, Ahn H, Cho JJ, et al. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J 2002; 16: 1633-1635.
24. Doyle V, Virji S, Crompton M. Evidence that cyclophilin-A protects cells against oxidative stress. Biochem J 1999; 341: 127-132.
25. Sawicki G, Dakour J, Morrish DW. Functional proteomics of neurokinin B in the placenta indicates a novel role in regulating cytotrophoblast antioxidant defences. Proteomics 2003; 3: 2044-2051.
26. Lee SP, Hwang YS, Kim YJ, Kwon KS, Kim HJ, Kim K, et al. Cyclophilin a binds to peroxiredoxins and activates its peroxidase activity. J Biol Chem 2001; 276: 29826-29832.
27. Gozal E, Sachleben LR Jr, Rane MJ, Vega C, Gozal D. Mild sustained and intermittent hypoxia induce apoptosis in PC12 cells via different mechanisms. Am J Physiol Cell Physiol 2005; 288: C535-C542.
28. Koh SH, Kwon H, Park KH, Ko JK, Kim JH, Hwang MS, et al. Protective effect of diallyl disulfide on oxidative stress-injured neuronally differentiated PC12 cells. Brain Res Mol Brain Res 2005; 133: 176-186.
29. Gao X, Tang XC. Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism. J Neurosci Res 2006; 83: 1048-1057.
30. Lin YH, Liu AH, Wu HL, Westenbroek C, Song QL, Yu HM, et al. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents A beta (25-35)-induced reduction in BPRP in PC12 cells. Biochem Biophys Res Commun 2006; 348: 593-599.
31. Zeng H, Chen Q, Zhao B. Genistein ameliorates beta-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis. Free Radic Biol Med 2004; 36:180-188.
32. Song J, Lu YC, Yokoyama K, Rossi J, Chiu R. Cyclophilin A is required for retinoic acid-induced neuronal differentiation in p19 cells. J Biol Chem 2004; 279: 24414-24419.
33. Arckens L, Van der Gucht E, Van den Bergh G, Massie A, Leysen I, Vandenbussche E, et al. Differential display implicates cyclophilin A in adult cortical plasticity. Eur J Neurosci 2003; 18: 61-75.
34. Nahreini P, Hovland AR, Kumar B, Andreatta C, Edwards-Prasad J, Prasad KN. Effects of altered cyclophilin A expression on growth and differentiation of human and mouse neuronal cells. Cell Mol Neurobiol 2001; 21: 65-79.
35. Lee JP, Palfrey HC, Bindokas VP, Ghadge GD, Ma L, Miller RJ, et al. The role of immunophilins in mutant superoxide dismutase-1linked familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 1999; 96: 3251-3256.
36. Varadarajan S, Yatin S, Aksenova M, Butterfield DA. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 2000; 130: 184-208.
37. Gilgun-Sherki Y, Melamed E, Offen D. Antioxidant treatment in Alzheimer's disease: current state. J Mol Neurosci 2003; 21: 1-11.
38. 25-35 induced oxidative damage in cultured rat hippocampal neurons. Endocrine 2007; 32: 206-211.
39. Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder JB, et al. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxid Redox Signal 2007; 9: 1659-1675.
40. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269-290.
41. Ferreiro E, Resende R, Costa R, Oliveira CR, Pereira CM. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol Dis 2006; 23: 669-678.
42. Nishida H, Kushida M, Nakajima Y, Ogawa Y, Tatewaki N, Sato S, et al. Amyloid-beta-induced cytotoxicity of PC-12 cell was attenuated by Shengmai-san through redox regulation and outgrowth induction. J Pharmacol Sci 2007; 104: 73-81.
43. Jang MH, Piao XL, Kim HY, Cho EJ, Baek SH, Kwon SW, et al. Resveratrol oligomers from Vitis amurensis attenuate beta-amyloid-induced oxidative stress in PC12 cells. Biol Pharm Bull 2007; 30: 1130-1134.